These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

624 related items for PubMed ID: 8070517

  • 1. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls.
    Han SH, Hulette C, Saunders AM, Einstein G, Pericak-Vance M, Strittmatter WJ, Roses AD, Schmechel DE.
    Exp Neurol; 1994 Jul; 128(1):13-26. PubMed ID: 8070517
    [Abstract] [Full Text] [Related]

  • 2. Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: implications for disease pathogenesis.
    Richey PL, Siedlak SL, Smith MA, Perry G.
    Biochem Biophys Res Commun; 1995 Mar 17; 208(2):657-63. PubMed ID: 7695621
    [Abstract] [Full Text] [Related]

  • 3. Apolipoprotein E immunoreactivity in neurons and neurofibrillary degeneration of aged non-demented and Alzheimer's disease patients.
    Gómez-Ramos P, Mufson EJ, Morán MA.
    Microsc Res Tech; 2001 Oct 01; 55(1):48-58. PubMed ID: 11596149
    [Abstract] [Full Text] [Related]

  • 4. The expression of calcium/calmodulin-dependent protein kinase II-alpha in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology.
    Wang YJ, Chen GH, Hu XY, Lu YP, Zhou JN, Liu RY.
    Brain Res; 2005 Jan 07; 1031(1):101-8. PubMed ID: 15621017
    [Abstract] [Full Text] [Related]

  • 5. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
    van de Nes JA, Nafe R, Schlote W.
    Brain Res; 2008 Jun 05; 1213():152-65. PubMed ID: 18455153
    [Abstract] [Full Text] [Related]

  • 6. [Apolipoprotein E4 and late-onset Alzheimer's disease].
    Tamaoka A.
    Nihon Rinsho; 1994 Dec 05; 52(12):3257-65. PubMed ID: 7853720
    [Abstract] [Full Text] [Related]

  • 7. Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease.
    Benzing WC, Ikonomovic MD, Brady DR, Mufson EJ, Armstrong DM.
    J Comp Neurol; 1993 Aug 08; 334(2):176-91. PubMed ID: 7690048
    [Abstract] [Full Text] [Related]

  • 8. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
    Sasaki N, Fukatsu R, Tsuzuki K, Hayashi Y, Yoshida T, Fujii N, Koike T, Wakayama I, Yanagihara R, Garruto R, Amano N, Makita Z.
    Am J Pathol; 1998 Oct 08; 153(4):1149-55. PubMed ID: 9777946
    [Abstract] [Full Text] [Related]

  • 9. Selective PrP-like protein, doppel immunoreactivity in dystrophic neurites of senile plaques in Alzheimer's disease.
    Ferrer I, Freixas M, Blanco R, Carmona M, Puig B.
    Neuropathol Appl Neurobiol; 2004 Aug 08; 30(4):329-37. PubMed ID: 15305978
    [Abstract] [Full Text] [Related]

  • 10. Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer's disease.
    Woodhouse A, Shepherd CE, Sokolova A, Carroll VL, King AE, Halliday GM, Dickson TC, Vickers JC.
    Acta Neuropathol; 2009 Jan 08; 117(1):19-29. PubMed ID: 19015863
    [Abstract] [Full Text] [Related]

  • 11. Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease.
    Schwab C, Hosokawa M, McGeer PL.
    Exp Neurol; 2004 Jul 08; 188(1):52-64. PubMed ID: 15191802
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease.
    Williams S, Chalmers K, Wilcock GK, Love S.
    Neuropathol Appl Neurobiol; 2005 Aug 08; 31(4):414-21. PubMed ID: 16008825
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Neuritic pathology and dementia in Alzheimer's disease.
    McKee AC, Kosik KS, Kowall NW.
    Ann Neurol; 1991 Aug 08; 30(2):156-65. PubMed ID: 1910274
    [Abstract] [Full Text] [Related]

  • 17. Cerebral beta-amyloid deposition is augmented by the -491AA promoter polymorphism in non-demented elderly individuals bearing the apolipoprotein E epsilon4 allele.
    Pahnke J, Walker LC, Schroeder E, Vogelgesang S, Stausske D, Walther R, Warzok RW.
    Acta Neuropathol; 2003 Jan 08; 105(1):25-9. PubMed ID: 12471457
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.